Related Experiment Video

Updated: Jun 30, 2025

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

60.3K

Accessory oligos for neuronal delivery of therapeutic siRNAs for ALS

John J Rossi1

  • 1Center for RNA Biology and Therapeutics, Beckman Research Institute of the City of Hope, Monrovia, CA 91016, USA.

Molecular Therapy. Nucleic Acids
|March 21, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ASOASO deliveryaccessory oligonucleotidesamyotrophic lateral sclerosisin vivosiRNA

More Related Videos

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.5K
Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
07:47

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Published on: October 29, 2019

18.5K

Related Experiment Videos

Last Updated: Jun 30, 2025

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

60.3K
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.5K
Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
07:47

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Published on: October 29, 2019

18.5K

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi02:15

Experimental RNAi

6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K

Articles linked to this work by shared authors, journal, and citation graph.

Revisiting long-standing biological questions through evolving technologies.

Bioscience trends·2026

RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.

Frontiers in medicine·2026

C/EBPβ stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

A hypoxia-responsive tRNA-derived small RNA confers renal protection through RNA autophagy.

Science (New York, N.Y.)·2025

Small RNAs as therapeutic agents: From catalytic motifs to regulatory pathways.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.

Cell reports. Medicine·2025

Integrated in vitro transcription and oligo-dT affinity chromatography enable multi-cycle reagent recycling for mRNA manufacturing.

Molecular therapy. Nucleic acids·2026

Cas12a chRDNA-mediated in vivo genome editing for high specificity functional gene disruption.

Molecular therapy. Nucleic acids·2026

Codon-dependent translation of N1-ethylpseudouridine-modified mRNA reduces innate immunity while preserving vaccine immunogenicity.

Molecular therapy. Nucleic acids·2026

Emerging strategies and innovations in circular RNA synthesis.

Molecular therapy. Nucleic acids·2026

Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells.

Molecular therapy. Nucleic acids·2026

An mRNA-lipid nanoparticle vaccine targeting the Plasmodium vivax E140 antigen.

Molecular therapy. Nucleic acids·2026

Vagal neuroimmune circuits in inflammation and immunity.

The Journal of experimental medicine·2026

Circadian Norepinephrine Rhythm Regulates Outflow Facility and IOP in Rat Eyes.

Investigative ophthalmology & visual science·2026

[Cardioneuroablation for vasovagal syncope: rationale, evidence, and limitations of an emerging therapy].

Giornale italiano di cardiologia (2006)·2026

Neurotransmitters as regulators of autoimmunity: mechanisms and translational targeting.

NPJ autoimmunity·2026

Cerebrospinal fluid protein elevations in Alzheimer's disease are dissociated from immune cell composition.

Alzheimer's & dementia (New York, N. Y.)·2026

Interoception network in the rat brain.

Imaging neuroscience (Cambridge, Mass.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us